Incidence of cytomegalovirus reactivation in patients with inflammatory connective tissue diseases who are under immunosuppressive therapy

Journal of Rheumatology

Volumn 31, Issue 7, 2004, Pages 1349-1351

  Mori, Takehiko ^a,b   Kameda, Hideto ^a   Ogawa, Hiroe ^a   Iizuka, Atsushi ^a   Sekiguchi, Naoya ^a   Takei, Hirofumi ^a   Nagasawa, Hayato ^a   Tokuhira, Michihide ^a   Tanaka, Toshio ^c   Saito, Yumiko ^c   Amano, Koichi ^a   Abe, Toru ^a   Takeuchi, Tsutomu ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SRL INC   (Japan)

Author keywords

Cytomegalovirus; Inflammatory connective tissue disease; Reactivation

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA DETERMINATION; DRUG INDICATION; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFLAMMATORY DISEASE; LEUKOCYTE; MALE; NONHUMAN; PLASMA; PNEUMONIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS REACTIVATION;

ADULT; AGED; CONNECTIVE TISSUE DISEASES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RECURRENCE;

EID: 3042845120     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus. Arthritis Rheum 1995;38:1492-9.
2. Bulpitt KJ, Brahn E. Systemic lupus erythematosus and concurrent cytomegalovirus vasculitis: diagnosis by antemortem skin biopsy. J Rheumatol 1989;16:677-80.
3. Ikura Y, Matsuo T, Ogami M, et al. Cytomegalovirus-associated pancreatitis in a patient with systemic lupus erythematosus. J Rheumatol 2000;27:2715-7.
4. Garcia-Porrua C, Gonzalez-Gay MA, Perez de Llano LA, Alvarez-Ferreira J. Fatal interstitial pneumonia due to cytomegalovirus following cyclophosphamide treatment in a patient with systemic lupus erythematosus. Scand J Rheumatol 1998;27:465-6.
5. Aglas F, Riner F, Hermann J, et al. Interstitial pneumonia due to cytomegalovirus following low-dose methotrexate treatment for rheumatoid arthritis. Arthritis Rheum 1995;38:291-2.
6. Fraenkel G, Ross B, Wong H-C. Cytomegalovirus retinitis in a patient with rheumatoid arthritis being treated with combination immunosuppressive therapy. Retina 1995;15:169-70.
7. Rider JR, Ollier WER, Lock RJ, Brookes ST, Pamphilon DH. Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol 1997;15:405-9.
8. Bendiksen S, Van Ghelue M, Rekvig OP, Gutteberg T, Haga H-J, Moens U. A longitudinal study of human cytomegalovirus serology and viruria fails to detect active viral infection in 20 systemic lupus erythematosus patients. Lupus 2000;9:120-6.
9. Hochberg MC. Updating the American College of Rheumatology Revised Criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
10. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of 2 parts). N Engl J Med 1975;292:344-7.
11. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of 2 parts). N Engl J Med 1975;292:403-7.
12. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
13. Masi AT, Rodnan GP, Medsger TA Jr, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
14. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
15. Tanaka N, Kimura H, Iida K, et al. Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J Med Virol 2000;60:455-62.
16. Einsele H, Ehninger G, Hebart H, et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995;86:2815-20.
17. Mori T, Okamoto S, Matsuoka S, et al. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;25:765-9.
18. Mori T, Okamoto S, Watanabe R, et al. Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002;29:777-82.
19. Ku S-C, Yu C-J, Chang Y-L, Yang P-C. Disseminated cytomegalovirus disease in a patient with systemic lupus erythematosus not undergoing immunosuppressive therapy. J Formosa Med Assoc 1999;98:855-8.
20. Vasquez V, Barzaga RA, Cunha BA. Cytomegalovirus-induced flare-up of systemic lupus erythematosus. Heart Lung 1992;21:407-8.
21. Hayashi T, Lee S, Ogasawara H, et al. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus 1998;7:561-4.